BD to Double Syringe Production Capacity in Tatabánya
2022. 03. 01.
Becton Dickinson (BD), one of the world’s leading medical technology companies, announced an investment of 210 million dollars that amounts to nearly one-fifth of its global development budget earmarked for the upcoming years. The project, which will create more than 300 new jobs, will result in three new production lines thanks to which the production of pre-filled glass syringes can be doubled in the Tatabánya plant.
With a presence in 190 countries, BD opened its pre-filled glass syringe manufacturing plant in Hungary in 2009 and has been continuously developing ever since; therefore, among others, the company has brought the production of product groups requiring high expertise such as biotechnological reagents to Hungary.
The US company, which has a history of 125 years, will invest USD 1.2 billion globally in the coming years to improve and expand its manufacturing technology, and one of the most important elements of the program is the Tatabánya project. BD Hungary Kft.’s development will enable the production of hundreds of millions of syringes, the new production lines are expected to be operational by the end of 2024.
Related articles
Sector articles
Danish-based Xellia Pharmaceuticals is investing €70.85 million in Szigetszentmiklós, further strengthening Hungary's role in the European healthcare and antibiotic supply chain. The development aims to create a modern, automated pharmaceutical manufacturing pla...
2026. 03. 06.
Life Sciences #Life SciencesHungarian-owned Biolab Zrt. is strengthening Pest County through a capacity expansion investment.
2026. 02. 25.
Life Sciences #Life SciencesFrench-owned Hungarian pharmaceutical company Egis Gyógyszergyár Zrt. is set to implement another large-scale investment to boost efficiency and capacity at its base in Körmend.
2025. 07. 28.
Life Sciences #Life Sciences